SARS-CoV-2 IgG Antibodies Seroprevalence and Sera Neutralizing Activity in MEXICO: A National Cross-Sectional Study during 2020
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
SARS-CoV-2 IgG Antibodies Seroprevalence and Sera Neutralizing Activity in MEXICO: A National Cross-Sectional Study during 2020
Authors
Keywords
-
Journal
Microorganisms
Volume 9, Issue 4, Pages 850
Publisher
MDPI AG
Online
2021-04-16
DOI
10.3390/microorganisms9040850
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
- (2020) Chaolin Huang et al. LANCET
- A Novel Coronavirus from Patients with Pneumonia in China, 2019
- (2020) Na Zhu et al. NEW ENGLAND JOURNAL OF MEDICINE
- Performance Characteristics of the Abbott Architect SARS-CoV-2 IgG Assay and Seroprevalence in Boise, Idaho
- (2020) Andrew Bryan et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Severe Covid-19
- (2020) David A. Berlin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Molecular Diagnosis of COVID-19: Challenges and Research Needs
- (2020) Wei Feng et al. ANALYTICAL CHEMISTRY
- Clinical And Analytical Performance Of An Automated Serological Test That Identifies S1/S2 Neutralizing IgG In COVID-19 Patients Semiquantitatively.
- (2020) Fabrizio Bonelli et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Genomic Analysis of Early SARS-CoV-2 Variants Introduced in Mexico
- (2020) Blanca Taboada et al. JOURNAL OF VIROLOGY
- Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study
- (2020) Silvia Stringhini et al. LANCET
- A SARS-CoV-2 surrogate virus neutralization test based on antibody-mediated blockage of ACE2–spike protein–protein interaction
- (2020) Chee Wah Tan et al. NATURE BIOTECHNOLOGY
- Seroprevalence of immunoglobulin M and G antibodies against SARS-CoV-2 in China
- (2020) Xin Xu et al. NATURE MEDICINE
- Seroprevalence of Antibodies to SARS-CoV-2 in 10 Sites in the United States, March 23-May 12, 2020
- (2020) Fiona P. Havers et al. JAMA Internal Medicine
- The receptor binding domain of the viral spike protein is an immunodominant and highly specific target of antibodies in SARS-CoV-2 patients
- (2020) Lakshmanane Premkumar et al. Science Immunology
- COVID-19 Serological Tests: How Well Do They Actually Perform?
- (2020) Abdi Ghaffari et al. Diagnostics
- Molecular and Serological Tests for COVID-19. A Comparative Review of SARS-CoV-2 Coronavirus Laboratory and Point-of-Care Diagnostics
- (2020) Robert Kubina et al. Diagnostics
- Serologic testing of U.S. blood donations to identify SARS-CoV-2-reactive antibodies: December 2019-January 2020
- (2020) Sridhar V Basavaraju et al. CLINICAL INFECTIOUS DISEASES
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now